DiNAQOR partners with Siegfried to scale and commercialize DiNAMIQS as a best-in-class development and manufacturing platform for cell and gene therapies
ZURICH-SCHLIEREN, Switzerland, May 4, 2023 – DiNAQOR, an innovative genetic medicine company headquartered in Switzerland with subsidiaries in Laguna Hills/California/USA and Hamburg/Germany focused on proprietary human-based tissue drug development and technology to enable organ-specific delivery of gene therapies and other therapeutics, today announced that it will sell a 95% stake in its subsidiary DiNAMIQS to … Read more